Abstract
The activities of four heme-biosynthetic enzymes, δ-aminolevulinic acid (ALA) synthase, ALA dehydratase, porphobilogen (PBG) dearninase, and ferrochelatase, were studied in five epithelial cell lines of normal rat liver origin (Re, REC-10, RLC-24, M, Culb-TC) and five cell lines derived from Yoshida ascites hepatoma (JTC-1, JTC-2, JTC-15, JTC-16, JTC-24). The JTC series of hepatoma-derived cell lines exhibited decreased ALA synthase activity and increased ALA dehydratase activity, although the activities of all four enzymes and the Km values for their respective substrates varied widely from one cell line to another, a finding suggesting that specific regulatory mechanisms for porphyrin metabolism might operate in each cell type. M cells, which were transformed by 4-dimethylaminoazobenzene in vitro, gave the most abnormal Km values of heme-biosynthetic enzymes among all the cell lines studies, and were found to accumu2ate hematoporphyrin derivative (HpD).
Similar content being viewed by others
Abbreviations
- ALA:
-
o-aminolevulinic acid
- DAB:
-
4-dimethyl aminoazobenzene
- HpD:
-
hematoporphyrin derivative
- 4NQO:
-
4-nitroquinoline 1-oxide
- PBG:
-
porphobilinogen
References
ANDERSON, P.M. and DESNICK, R.J. (1980). “Purification and properties of uroporphyrinogen I synthase from human erythrocytes. Identification of stable enzyme substrate intermediates.” J. Biol. Chem. 255:1993–1999.
BONKOWSKY, H.L., BLOOMER, J.R., EBERT, P.S., and MAHONEY, M.J. (1975). “Heme synthetase deficiency in human protoporphyria: demonstration of the defect in liver and cultured skin fibroblasts.” J. Clin. Invest. 56:1139–1148.
HAYATA, Y., KATO, H., KONAKA, C., AMEMIA, R., ONO, J., OGAWA, I., KINOSHITA, K., SAKAI, H., TAKAHASHI, H. (1984). “Photoradiation therapy with hematoporphyrin derivative in early and stage I lung cancer”. Chest 86:169–177.
Hirota, N., Kawai, T., Takaoka, T., Kondo, M., Aoki, Y., and Yokoyama T. (1984). “Effect of hematoporphyrin derivative (HpD) and UV light on Cell strains derived from rat liver.” 43rd Proc. Jpn. Cancer Assoc. p. 185.
KAPPAS, A., SASSA, S., GALBRAITH, R.A., and NORDMANN, Y. (1989). “The porphyrias.” In: The Metabolic Basis of Inherited Disease (C.R. Scrivner et al., eds.). 6th ed. McGraw Hill, New York, NY pp. 1305–1365.
KATSUTA, H. and TAKAOKA, T. (1976). Methods in Cell Biology (D.M. Prescott, ed.), Vol. XIV. Academic Press, New York, NY. pp. 145–158.
Kondo, M., Urata, G., and Hirota, N. (1984). “Changes in porphyrin metabolism during rat hepatocarcinogenesis.” 43rd Proc. Jpn. Cancer Assoc. p. 341.
LITHNER F. and WETTERBE, L. (1984). “Hepatocellular carcinoma in patients with acute intermittent porphyria.” Act. Med. Sc. 215:271–274.
LOWRY, O.H., ROSEBROUGH, N.J., FARR, A.L., and RANDALL, R.J. (1951). “Protein measurement with the Folin-phenol reagent.” J. Biol. Chem. 193:265–271.
SHIONOYA, S., URABE, A., HASHIMOTO, Y., KONDO, M., and URATA, G. (1982). “Induction of δ-aminolevulinic acid synthase and δ-aminolevulinic acid dehydratase in normal human bone marrow cultures.” Stem Cell 2:145–154.
UDAGAWA, M., HORIE, Y., and HIRAYAMA, C. (1984). “Aberrant porphyrin metabolism in hepatocellular carcinoma.” Biochem. Med. 31:131–139.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kondo, M., Hirota, N., Takaoka, T. et al. Heme-biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat. Cell Biol Toxicol 9, 95–105 (1993). https://doi.org/10.1007/BF00755143
Issue Date:
DOI: https://doi.org/10.1007/BF00755143